Drugs / DW6012
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05403281 | Nov → Dec 2021 | — | Dong Wha Pharmaceutical Co. Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DW6012 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05403281 ↗ |
| Route | Oral | “Drug: DW6012 Single oral administration of DW6012 after an overnight fast” NCT05403281 ↗ |